Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ma, Dongjie, Li, Shanqing, Cui, Yushang, Li, Li, Liu, Hongsheng, Chen, Yeye, Zhou, Xiaoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859468/
https://www.ncbi.nlm.nih.gov/pubmed/33613708
http://dx.doi.org/10.3892/ol.2021.12480
_version_ 1783646740408172544
author Ma, Dongjie
Li, Shanqing
Cui, Yushang
Li, Li
Liu, Hongsheng
Chen, Yeye
Zhou, Xiaoyun
author_facet Ma, Dongjie
Li, Shanqing
Cui, Yushang
Li, Li
Liu, Hongsheng
Chen, Yeye
Zhou, Xiaoyun
author_sort Ma, Dongjie
collection PubMed
description
format Online
Article
Text
id pubmed-7859468
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-78594682021-02-18 Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway Ma, Dongjie Li, Shanqing Cui, Yushang Li, Li Liu, Hongsheng Chen, Yeye Zhou, Xiaoyun Oncol Lett Retraction D.A. Spandidos 2021-03 2021-01-21 /pmc/articles/PMC7859468/ /pubmed/33613708 http://dx.doi.org/10.3892/ol.2021.12480 Text en Copyright: © Ma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Ma, Dongjie
Li, Shanqing
Cui, Yushang
Li, Li
Liu, Hongsheng
Chen, Yeye
Zhou, Xiaoyun
Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title_full Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title_fullStr Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title_full_unstemmed Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title_short Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
title_sort paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via pi3k/akt pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859468/
https://www.ncbi.nlm.nih.gov/pubmed/33613708
http://dx.doi.org/10.3892/ol.2021.12480
work_keys_str_mv AT madongjie paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT lishanqing paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT cuiyushang paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT lili paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT liuhongsheng paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT chenyeye paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway
AT zhouxiaoyun paclitaxelincreasesthesensitivityoflungcancercellstolobaplatinviapi3kaktpathway

Ejemplares similares